The association of fever with transfusion-associated circulatory overload

Vox Sanguinis

Volumn 112, Issue 1, 2017, Pages 70-78

  Parmar, N ^a   Pendergrast, J ^a,b,c   Lieberman, L ^a,b,c   Lin, Y ^a,b,c,d   Callum, J ^a,b,c,d   Cserti Gazdewich, C ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Efficacy   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

blood components; blood safety; hemovigilance; transfusion medicine; transfusion reactions

Indexed keywords

THROMBOCYTE CONCENTRATE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; ATHEROMA; BLOOD SAFETY; BLOOD TRANSFUSION REACTION; CHILL; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GROUPS BY AGE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGOR; SYSTOLIC BLOOD PRESSURE; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; VASCULAR DISEASE; ADVERSE EFFECTS; AGE; BLOOD TRANSFUSION; FACTUAL DATABASE; HYPERSENSITIVITY; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDY; TIME FACTOR;

AGE FACTORS; BLOOD TRANSFUSION; DATABASES, FACTUAL; DYSPNEA; FEMALE; FEVER; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 85007391083     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12473     Document Type: Article

References (56)

1. Lieberman L, Maskens C, Cserti-Gazdewich C, et al.: A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev 2013; 27:206–212
2. Andrzejewski C Jr, Casey MA, Popovsky MA: How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention. Transfusion 2013; 53:3037–3047
3. Alam A, Lin Y, Lima A, et al.: The prevention of transfusion-associated circulatory overload. Transfus Med Rev 2013; 27:105–112
4. Raval JS, Mazepa MA, Russell SL, et al.: Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Vox Sang 2015; 108:387–392
5. Rana R, Fernandez-Perez ER, Khan SA, et al.: Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46:1478–1483
6. Clifford L, Jia Q, Yadav H, et al.: Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 2015; 122:21–28
7. Bolton-Maggs PH: Conference report: the 2015 SHOT symposium and report - what's new? Transfus Med 2015; 25:295–298
8. Health Canada Transfusion Transmitted Injuries Surveillance System, 2006 – 2012 Report 2014. http://www.phac-aspc.gc.ca/hcai-iamss/ttiss-ssit/ttiss-summary-ssti-summaire-2006-2012-eng.php#t_9 [Last accessed 4 October 2016]
9. U.S. Food and Drug Administration: Fatalities reported to FDA following blood collection and transfusion annual summary for FY2015. 2016. http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf [Last accessed 4 October 2016].
10. Delbanco T, Bell SK: Guilty, afraid, and alone–struggling with medical error. N Engl J Med 2007; 357:1682–1683
11. Maskens C, Downie H, Wendt A, et al.: Hospital-based transfusion error tracking from 2005 to 2010: identifying the key errors threatening patient transfusion safety. Transfusion 2014; 54:66–73
12. Haemovigilance ISoBTWPo: Transfusion associated circulatory overload 2014 revision. December 2014. http://www.isbtweb.org/fileadmin/user_upload/files-2015/haemovigilance/TACO_definition_validation_form_jan2015_haemovigilance.pdf [Last accessed 13 February 2016]
13. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol. 2014. http://www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf [Last accessed 13 February 2016]
14. Blumberg N, Heal JM, Gettings KF, et al.: An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50:2738–2744
15. Andrzejewski C Jr, Popovsky MA, Stec TC, et al.: Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion 2012; 52:2310–2320
16. Donadee C, Raat NJ, Kanias T, et al.: Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124:465–476
17. Liu C, Zhao W, Christ GJ, et al.: Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med 2013; 65:1164–1173
18. Vermeulen Windsant IC, de Wit NC, Sertorio JT, et al.: Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit Care 2012; 16:R95
19. Alexander JT, El-Ali AM, Newman JL, et al.: Red blood cells stored for increasing periods produce progressive impairments in nitric oxide-mediated vasodilation. Transfusion 2013; 53:2619–2628
20. Kim KN, Kim DW, Jeong MA: The usefulness of a classification and regression tree algorithm for detecting perioperative transfusion-related pulmonary complications. Transfusion 2015; 55:2582–2589
21. Andrzejewski C, Popovsky MA: Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion 2005; 45:1048–1050
22. Phipps RP, Kaufman J, Blumberg N: Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001; 357:2023–2024
23. Khan SY, Kelher MR, Heal JM, et al.: Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108:2455–2462
24. Heddle NM, Klama L, Singer J, et al.: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331:625–628
25. Janz DR, Zhao Z, Koyama T, et al.: Longer storage duration of red blood cells is associated with an increased risk of acute lung injury in patients with sepsis. Ann Intensive Care 2013; 3:33
26. Mastronardi C, Perkins H, Derksen P, et al.: Evaluation of the BacT/ALERT 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services. Clin Chem Lab Med 2010; 48:1179–1187
27. St Bernard R, Yan M, Ning S, et al.: Sustained and significant increase in reporting of transfusion reactions with the implementation of an electronic reporting system. Transfusion 2016; 56:1247–1248
28. Canada Public Health Agency: Transfusion Transmitted Injuries Surveillance System: User's Manual, Version 3.0; Transfusion Transmitted Injuries Section. Blood Safety Surveillance and Health Care Acquired Infections Division, Centre for Infectious Disease Prevention and Control. Queen's press, 66 pages. Report Number H40-6/2007E. 978-0-662-44215-8.
29. (OrbCon) ORBC: TTISS-ON Resources (Ontario Guide for Reporting Transfusion Reactions, Transfusion Reaction Chart). 2016. http://transfusionontario.org/en/cmdownloads/categories/ttiss_resources/[Last accessed 1 June 2016]
30. Pagani FD, Baker LS, Hsi C, et al.: Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 1992; 90:389–398
31. Haupt MT, Rackow EC: Adverse effects of febrile state on cardiac performance. Am Heart J 1983; 105:763–768
32. American Association of Blood Banks - Association Bulletin #15-02: Transfusion Associated Circulatory Overload (TACO). 12 February 2015. http://www.aabb.org/programs/publications/bulletins/Docs/ab15-02.pdf#search=bulletin%20%2315%2D02 [Last accessed 1 June 2016]
33. Robillard B, Itaj NK, Chapdelaine A: Increasing incidence of transfusion-associated circulatory overload reported to the Quebec Hemovigilance System, 2000-2006. Transfusion 2008; 48(S2):204A
34. Menis M, Izurieta HS, Anderson SA, et al.: Outpatient transfusions and occurrence of serious noninfectious transfusion-related complications among US elderly, 2007–2008: utility of large administrative databases in blood safety research. Transfusion 2012; 52:1968–1976
35. Hahn C, Schwartz MA: Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009; 10:53–62
36. Wang JC, Bennett M: Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012; 111:245–259
37. D'Alessandro A, Dzieciatkowska M, Hill RC, et al.: Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology. Transfusion 2016; 56:1329–1339
38. Li G, Daniels CE, Kojicic M, et al.: The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009; 49:13–20
39. Alexander PE, Barty R, Fei Y, et al.: Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. Blood 2016; 127:400–410
40. Weiser NJ, Kantor M, Russell HK: Postmyocardial infarction syndrome. Circulation 1959; 20:371–380
41. Risoe C, Kirkeby OJ, Grottum P, et al.: Fever after acute myocardial infarction in patients treated with intravenous timolol or placebo. Br Heart J 1987; 57:28–31
42. Calabro P, Golia E, Yeh ET: Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches. Curr Pharm Biotechnol 2012; 13:4–16
43. Kapur R, Kim M, Shanmugabhavananthan S, et al.: C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury. Blood 2015; 126:2747–2751
44. Bentzon JF, Otsuka F, Virmani R, et al.: Mechanisms of plaque formation and rupture. Circ Res 2014; 114:1852–1866
45. Edgren G, Kamper-Jorgensen M, Eloranta S, et al.: Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010; 50:1185–1195
46. Koch CG, Li L, Sessler DI, et al.: Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229–1239
47. van Lammeren GW, Moll FL, Borst GJD, et al.: Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque. Curr Cardiol Rev 2011; 7:22–27
48. Li N, Williams L, Zhou Z, et al.: Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system. Transfusion 2014; 54:1666–1672
49. Maitland K, Kiguli S, Opoka RO, et al.: Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483–2495
50. Piccin A, Cronin M, Brady R, et al.: Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010. Transfusion 2015; 55:1223–1230
51. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al.: B-type natriuretic peptide and plasma hemoglobin levels following transfusion of shorter-storage versus longer-storage red blood cells: results from the TOTAL randomized trial. Am Heart J 2016; doi: 10.1016/j.ahj.2016.01.007. [Epub ahead of print].
52. Mohapatra SS: Role of natriuretic peptide signaling in modulating asthma and inflammation. Can J Physiol Pharmacol 2007; 85:754–759
53. Chiurchiu V, Izzi V, D'Aquilio F, et al.: Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages. Regul Pept 2008; 148:26–32
54. Pataki I, Jaszberenyi M, Telegdy G: Hyperthermic effect of centrally administered natriuretic peptides in the rat. Peptides 1999; 20:193–197
55. Vollmar AM: The role of atrial natriuretic peptide in the immune system. Peptides 2005; 26:1086–1094
56. Casserly BP, Sears EH, Gartman EJ: The role of natriuretic peptides in inflammation and immunity. Recent Pat Inflamm Allergy Drug Discov 2010; 4:90–104